Page 38 - Journal of Structural Heart Disease Volume 3, Issue 3

91
Meeting Abstracts
Indication for Intervention: Limb ischemia
Figure 1. Postprocedural 36 hours CTA revealed complete occlusion of left common femoral artey, 2.8 cm in length.
Figure 2. Postprocedural 2 months CAT revealed complete occlusion of left common femoral artery, 3.6 cm in length with collateral arteries.
Intervention: Surgical thromboembolectomy
Learning Points of the Procedure:
1. Excessive compression not only contributed vascular stasis but
also precipitated arterial spasm which is the major mechanism of vessel-related thrombosis.
2. Late detection of vascular insu ciency had been an important factor on the thrombosis and ischemic progression.
3. Thrombolysis should be an appropriated treatment for the pa- tients whom has no contraindications with the aim to improve vascular supply and avoid surgical complications.
4. Bolus heparin prophylaxis should be changed to 100 units/kg to achieve the best e cacy, particular in the high-risk patients.
MID-TERM RESULTS OF PERCUTANEOUS VSD CLOSURE WITH ADO II IN PEDIATRIC POPULATION Ozge Pamukcu, Nazmi Narin, Ali Baykan, Suleyman Sunkak, Onur Tasci, Kazim Uzum
Erciyes University, Pediatric Cardiology, Kayseri, Turkey
Background: Nowadays percutaneous VSD closure is accepted as an alternative surgery but still no ideal device was determined for the pediatric population.
Objective: The aim of this study was to share mid-term results of per- cutaneous VSD closure with ADO II in pediatric population.
Methods: VSD closures of 49 patients with ADO-II device was per- formed in Erciyes University Medical Faculty Children Hospital, Pediatric Cardiology Department.
Results: Mean age of patients: 86.8±52.6 months. The youngest patient was 4 months old and the oldest patient was 18 years old. 19 patients were female and 30 were male. Weight of the patients was between 24.3±16 kg (Range: 5-76 kg). Mean diameter of VSD was 3.7±1,4 mm. Mean uoroscopy and total procedure time were 37±19.3, 74.1±27 minutes respectively. We have used two ADOII-AS devices. VSD types were muscular in 6 patients, rest of the defects were all perimembranous type. No major complications like death, vascular complications, device embolizations were seen. One com- plete AV block was seen 6 months after the procedure and a pace- maker was implanted.
Conclusion: To our knowledge our study includes the largest series of pediatric patients on whom percutaneous VSD closure was done with an ADO II device. When all complications within the 42 months follow-up period are taken into consideration, the ADO II device is a good choice in selected cases for VSD closure even in the infants less than 1 year of age.
Hijazi, Z
20th Annual PICS/AICS Meeting Abstracts